Universal Health Services, Inc. (UHS) Competitors & Peers
The 5 largest companies in the same industry as Universal Health Services, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| HCA | Competitor | $428.59 | P/E 14.4RSI 60Cap 92.8 B |
| FSNUF | Peer | $54.35 | P/E 17.4RSI 97Cap 30.6 B |
| FSNUY | Peer | $13.26 | P/E 16.7RSI 57Cap 30.1 B |
| THC | Peer | $258.96 | P/E 10.2RSI 49Cap 20.9 B |
| DVA | Peer | $183.29 | P/E 16.5RSI 60Cap 12.5 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- HCACompetitor
Universal Health Services operates acute care hospitals and behavioral health clinics, competing with HCA Healthcare for patients, physician partnerships, and healthcare personnel in shared markets.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- UEPartner
UHS acts as the primary tenant leasing hospital properties from UE.
Model-inferred, unverified — treat as a lead, not evidence - ACHCCompetitor
Competes directly in providing inpatient behavioral health and psychiatric facilities.
Model-inferred, unverified — treat as a lead, not evidence - IQVPartner
IQVIA provides contract clinical research and trial management services (CRO).
Model-inferred, unverified — treat as a lead, not evidence - AMZNSupplier
Utilizes AWS cloud infrastructure to host genomic sequencing data and clinical trial databases.
Model-inferred, unverified — treat as a lead, not evidence - PFECompetitor
Competes in development and commercialization of therapeutics for similar indications.
Model-inferred, unverified — treat as a lead, not evidence